BDR Pharmaceuticals in license pact with DRDO for manufacturing 2-DG Covid drug

The DRDE in Gwalior had produced 2-DG and clinical trials were carried out in collaboration with Dr. Reddy's Laboratories by INMAS, a DRDO lab. DCGI had allowed phase-III trials of 2-DG in November last year